Latest filing published 04 Jan 2024 for BICYCLE THERAPEUTICS plc.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -41.3%Entry US$2.40 · Close at T+365 US$1.41
- -12.0%Entry US$25.05 · Close at T+365 US$22.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Veronica GH Jordan: trading record in brief
This profile gathers the share dealings of Veronica GH Jordan across 3 companies, led by Aspira Women's Health Inc., Albany Molecular Research Inc and BICYCLE THERAPEUTICS plc. Over a trading history stretching from 30 October 2006 to 2 January 2024, the count stands at 33 filings.
No open-market sale appears; the market trades are 4 purchases worth €55k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 29 share grants.
A typical purchase (the median) is worth €13k.
The latest filing, published on 4 January 2024, reports a share grant in BICYCLE THERAPEUTICS plc. The last purchase on record was published on 24 July 2023, which is 1,204 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Veronica GH Jordan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares0Ordinary SharesSEC:0001209191-24-000883:0
- 7,045 shares0Common StockSEC:0001381123-23-000005:0
- 7,045 shares0Common stockSEC:0001381123-23-000004:0
- 3,769 shares@ US$3.98100.0% of flowCommon stockSEC:0001381123-23-000003:0Canonical exit: 22 Oct 2023 (T+90)
- 4,385 shares0Common StockSEC:0001381123-23-000002:0
- 35,225 shares0COMMON STOCKSEC:0001381123-23-000001:0
- 5,750 shares0Ordinary SharesSEC:0001209191-23-002223:0
- 11,516 shares0Common StockSEC:0001381123-22-000001:1
- 62,140 shares0Common StockSEC:0001381123-22-000001:0
- 5,000 shares0Ordinary SharesSEC:0001209191-22-001867:0
- 16,442 shares0Common StockSEC:0001381123-21-000001:0
- 5,021 shares@ US$1.8037.0% of flowCommon StockSEC:0001562762-20-000219:0
- 70,467 shares0Common StockSEC:0001562762-20-000125:0
- 37,689 shares0Common StockSEC:0001562762-19-000083:0
- 79,600 shares0Common StockSEC:0001562762-18-000133:0
- 25,602 shares0Common StockSEC:0000926617-17-000019:0
- 6,695 shares@ US$1.4029.1% of flowCommon Stock, par value $0.001SEC:0000926617-17-000008:0Canonical exit: 14 May 2017 (T+90)
- 35,909 shares0Common StockSEC:0000899243-16-016349:0
- 2,854 sharesCommon StockSEC:0001638599-16-000618:0
- 27,711 shares0Common StockSEC:0001381123-15-000001:0
- 1,165 shares@ US$17.16Common StockSEC:0001179110-14-009925:0
- 1,434 shares@ US$10.46Common StockSEC:0001179110-13-009850:0
- 2,918 shares@ US$5.14Common StockSEC:0001179110-11-009175:0
- 4,878 shares@ US$6.15Common StockSEC:0001179110-10-009916:0
- 1,075 shares@ US$13.95Common StockSEC:0001179110-08-011552:0
25 of 27 declarations
